Written by Jose-Alberto Palma, MD, PhD and Horacio Kaufmann, MD
Neurogenic orthostatic hypotension (nOH) is a condition that is part of a larger category called orthostatic hypotension (OH), which is also known as postural hypotension. nOH is caused by dysfunction in the autonomic nervous system and causes people to feel faint when they stand or sit up. Learn more about nOH in the first part of our article.
The good news is that nOH is treatable. The goal of treatment is not to achieve normal blood pressure values, but rather, to reduce symptoms of nOH and improve your quality of life.
Management of nOH includes three components:
- Correcting aggravating factors
- Lifestyle changes
Correcting aggravating factors
Stay Informed On Your Parkinson’s Journey
Would you like to learn more about nOH and living well with Parkinson’s?
Our Every Victory Counts® manual gives people living with Parkinson’s, their care partners and their family members the tools they need to take control of their own Parkinson’s treatment through a proactive approach to self-care.
Dr. Jose-Alberto Palma is Assistant Professor of Neurology and Assistant Director of the Dysautonomia Center at New York University. His work over the past years has been focused on the diagnosis, management and understanding on autonomic disorders in patients with autonomic synucleinopathies, such as Parkinson disease and multiple system atrophy, as well as in the search for biomarkers for early diagnosis of these disorders. He has been involved in several studies and clinical trials to develop new treatments for autonomic dysfunction, and to describe the premotor phase of Parkinson disease.
Dr. Horacio Kaufmann is Professor of Neurology and Medicine and the Director of the Dysautonomia Center at New York University. He is one of the world leading experts in the diagnosis and management of patients with autonomic synucleinopathies (Parkinson disease and multiple system atrophy), a subject that has been the focus of his research and academic career over the last 25 years. He has extensive experience as the principal investigator of national and international studies on autonomic dysfunction, including clinical trials for orthostatic hypotension, and identification and development of biomarker for early diagnosis and progression of Parkinson disease and related disorders.